| Abstract: |
Fever remains one of the most common clinical presentations encountered across primary and tertiary healthcare, and the search for safer, plant-derived antipyretic alternatives to conventional non-steroidal anti-inflammatory drugs continues to attract considerable research attention. Momordica dioica Roxb. ex Willd. (Cucurbitaceae), commonly known as spiny gourd or kakrol, is a dioecious climbing herb widely distributed across the Indian subcontinent and South-East Asia, traditionally used in folk medicine for the management of fever, inflammation, diabetes, and hepatic disorders. This review consolidates and critically synthesises past experimental, phytochemical, and pharmacological literature concerning the antipyretic potential of Momordica dioica leaf extracts, with the objective of establishing a coherent evidence base for future pharmacological validation. A structured meta-analytic approach was adopted, wherein peer-reviewed studies employing yeast-induced and lipopolysaccharide-induced pyrexia models were systematically compared across extraction solvents, dose ranges, and percentage reduction in rectal temperature relative to paracetamol as the reference standard. The collective evidence indicates that methanolic and aqueous leaf extracts of Momordica dioica, rich in flavonoids, saponins, and triterpenoids, produce dose-dependent antipyretic activity comparable to, though generally milder than, standard antipyretic agents. Mechanistic discussions converge upon cyclooxygenase and prostaglandin E2 inhibition as the probable pathway. The review further identifies methodological inconsistencies, inadequate standardisation of extracts, and limited mechanistic validation as recurring gaps across the surveyed literature. This paper concludes by proposing a standardised experimental framework to guide future investigations into the antipyretic pharmacology of this underexplored medicinal plant. |